Gossamer Bio, Inc. (GOSS)
NASDAQ: GOSS · Real-Time Price · USD
0.3406
+0.0019 (0.56%)
At close: May 12, 2026, 4:00 PM EDT
0.3406
0.00 (0.00%)
Pre-market: May 13, 2026, 8:15 AM EDT
Gossamer Bio Market Cap
Gossamer Bio has a market cap or net worth of $79.94 million as of May 13, 2026. Its market cap has decreased by -59.86% in one year.
Market Cap
79.94M
Enterprise Value
145.91M
1-Year Change
-59.86%
Ranking
Category
Stock Price
$0.34
Market Cap Chart
Since February 8, 2019, Gossamer Bio's market cap has decreased from $995.26M to $79.94M, a decrease of -91.97%. That is a compound annual growth rate of -29.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 12, 2026 | 79.94M | -88.86% |
| Dec 31, 2025 | 717.51M | 250.03% |
| Dec 31, 2024 | 204.99M | -0.34% |
| Dec 29, 2023 | 205.69M | 0.56% |
| Dec 30, 2022 | 204.54M | -76.06% |
| Dec 31, 2021 | 854.34M | 21.87% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Feb 8, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| eXoZymes | 83.77M |
| Atara Biotherapeutics | 83.51M |
| Adicet Bio | 83.48M |
| Acrivon Therapeutics | 80.89M |
| MAIA Biotechnology | 79.48M |
| Annovis Bio | 78.73M |
| Alterity Therapeutics | 78.51M |
| Gain Therapeutics | 76.78M |